Global Liquid Biopsy Market to Grow at a CAGR of 20.3%, 2017-2021 With Biocept, Exosome Diagnostics, QIAGEN & Roche Molecular Diagnostics Dominating - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Liquid Biopsy Market 2017-2021" report to their offering.

The global liquid biopsy market to grow at a CAGR of 20.31% during the period 2017-2021.

The report, Global Liquid Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

New players approach venture capitalists to enter into niche markets like a liquid biopsy. These venture capitalists started realizing the significant potential of start-ups that develop innovative technologies and products in the area of cancer. This has increased the financial flow support from venture capitalists, which is accelerating the development of liquid biopsy products and is leading to the market entry of start-ups. Post registration and market approvals, venture capitalists take a share from the total revenue generated by the start-ups.

According to the report, the Americas is the major contributor in the market. The rising older population in the Americas is one of the major factors for increased adoption of liquid biopsy tests. Aging causes the immune system of the body to deteriorate. This makes most people aged 60 and above susceptible to chronic diseases such as cancer and cardiovascular diseases. The incidence of breast cancer and colorectal cancer is increasing due to the rise in the number of older people.

Key vendors

  • Biocept
  • Exosome Diagnostics
  • QIAGEN
  • Roche Molecular Diagnostics

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Key vendor analysis

PART 16: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/m5wtgp/global_liquid.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics